"Alliance Clinical Research of Tampa is a clinical research site where new drugs/medical treatments are available to qualified participants. Through clinical research, we provide access to free health care while advancing the medical solutions of tomorrow. Check our website for actively enrolling studies."

During the past decade, Alliance Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alliance Clinical Research" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Iroko Pharmaceuticals, LLC" with 2 trials sponsored, "Alkermes, Inc." with 1 trials sponsored, "Frank C Sciurba" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alliance Clinical Research" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Alliance Clinical Research" are "Crohn's Disease" (3 trials), "Osteoarthritis" (2 trials), "COVID-19" (1 trials), "Diarrhea Predominant Irritable Bowel Syndrome" (1 trials) and "Opioid Dependence" (1 trials). Many other conditions were trialed in "Alliance Clinical Research" in a lesser frequency.

Most popular intervention types in "Alliance Clinical Research" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Diclofenac" (2 trials), "Mirikizumab" (2 trials), "Ustekinumab" (2 trials) and "Apixaban 2.5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alliance Clinical Research" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Alliance Clinical Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Alliance Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alliance Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".